284 related articles for article (PubMed ID: 15916817)
1. Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells.
Weng TY; Chen LC; Shyu HW; Chen SH; Wang JR; Yu CK; Lei HY; Yeh TM
Antiviral Res; 2005 Jul; 67(1):31-7. PubMed ID: 15916817
[TBL] [Abstract][Full Text] [Related]
2. Recombinant porcine lactoferrin expressed in the milk of transgenic mice protects neonatal mice from a lethal challenge with enterovirus type 71.
Chen HL; Wang LC; Chang CH; Yen CC; Cheng WT; Wu SC; Hung CM; Kuo MF; Chen CM
Vaccine; 2008 Feb; 26(7):891-8. PubMed ID: 18207613
[TBL] [Abstract][Full Text] [Related]
3. Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro.
Lin TY; Chu C; Chiu CH
J Infect Dis; 2002 Oct; 186(8):1161-4. PubMed ID: 12355368
[TBL] [Abstract][Full Text] [Related]
4. Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice.
Wu TC; Wang YF; Lee YP; Wang JR; Liu CC; Wang SM; Lei HY; Su IJ; Yu CK
J Virol; 2007 Oct; 81(19):10310-5. PubMed ID: 17626076
[TBL] [Abstract][Full Text] [Related]
5. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection.
Chen HL; Huang JY; Chu TW; Tsai TC; Hung CM; Lin CC; Liu FC; Wang LC; Chen YJ; Lin MF; Chen CM
Vaccine; 2008 Jun; 26(23):2882-9. PubMed ID: 18450335
[TBL] [Abstract][Full Text] [Related]
6. Recombinant VP1 protein expressed in Pichia pastoris induces protective immune responses against EV71 in mice.
Wang M; Jiang S; Wang Y
Biochem Biophys Res Commun; 2013 Jan; 430(1):387-93. PubMed ID: 23159634
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo characterization of a new enterovirus type 71-specific human intravenous immunoglobulin manufactured from selected plasma donors.
Cao RY; Han JF; Jiang T; Tian X; Yu M; Deng YQ; Qin ED; Qin CF
J Clin Virol; 2011 Aug; 51(4):246-9. PubMed ID: 21641277
[TBL] [Abstract][Full Text] [Related]
8. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection.
Wang YF; Chou CT; Lei HY; Liu CC; Wang SM; Yan JJ; Su IJ; Wang JR; Yeh TM; Chen SH; Yu CK
J Virol; 2004 Aug; 78(15):7916-24. PubMed ID: 15254164
[TBL] [Abstract][Full Text] [Related]
9. The VP1 structural protein of enterovirus 71 interacts with human ornithine decarboxylase and gene trap ankyrin repeat.
Yeo WM; Chow VT
Microb Pathog; 2007 Apr; 42(4):129-37. PubMed ID: 17276651
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection.
Zhang G; Zhou F; Gu B; Ding C; Feng D; Xie F; Wang J; Zhang C; Cao Q; Deng Y; Hu W; Yao K
Arch Virol; 2012 Apr; 157(4):669-79. PubMed ID: 22245989
[TBL] [Abstract][Full Text] [Related]
11. Lactoferrin inhibits human papillomavirus binding and uptake in vitro.
Drobni P; Näslund J; Evander M
Antiviral Res; 2004 Oct; 64(1):63-8. PubMed ID: 15451180
[TBL] [Abstract][Full Text] [Related]
12. Enhanced potency and efficacy of 29-mer shRNAs in inhibition of Enterovirus 71.
Tan EL; Tan TM; Chow VT; Poh CL
Antiviral Res; 2007 Apr; 74(1):9-15. PubMed ID: 17316836
[TBL] [Abstract][Full Text] [Related]
13. Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant Newcastle disease virus capsids displaying the EV71 VP1 fragment.
Ch'ng WC; Stanbridge EJ; Ong KC; Wong KT; Yusoff K; Shafee N
J Med Virol; 2011 Oct; 83(10):1783-91. PubMed ID: 21837796
[TBL] [Abstract][Full Text] [Related]
14. [Expression of recombinant VP1 protein of enterovirus 71 and development of serological assay for detection of EV71 infection].
Zhou BP; Liu WL; Xie JJ; Chen XC; Xu LM; Tan Y; Liu YX; Yang GL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):492-4. PubMed ID: 19544656
[TBL] [Abstract][Full Text] [Related]
15. [In vitro study on the effect of ribavirin reducing the EV71 replication].
Zhang Y; Zhu Z; Zhu SL; An HQ; Yang ZH; Guo XB; Xu WB
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):44-6. PubMed ID: 19799016
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin.
Jenssen H; Sandvik K; Andersen JH; Hancock RE; Gutteberg TJ
Antiviral Res; 2008 Sep; 79(3):192-8. PubMed ID: 18456345
[TBL] [Abstract][Full Text] [Related]
17. RNA interference against enterovirus 71 infection.
Sim AC; Luhur A; Tan TM; Chow VT; Poh CL
Virology; 2005 Oct; 341(1):72-9. PubMed ID: 16083932
[TBL] [Abstract][Full Text] [Related]
18. Effects of lactoferrin-containing formula in the prevention of enterovirus and rotavirus infection and impact on serum cytokine levels: a randomized trial.
Yen MH; Chiu CH; Huang YC; Lin TY
Chang Gung Med J; 2011; 34(4):395-402. PubMed ID: 21880194
[TBL] [Abstract][Full Text] [Related]
19. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge.
Chung YC; Ho MS; Wu JC; Chen WJ; Huang JH; Chou ST; Hu YC
Vaccine; 2008 Mar; 26(15):1855-62. PubMed ID: 18329759
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rb1 is an immune-stimulatory agent with antiviral activity against enterovirus 71.
Kang N; Gao H; He L; Liu Y; Fan H; Xu Q; Yang S
J Ethnopharmacol; 2021 Feb; 266():113401. PubMed ID: 32980486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
